ISPOR Europe 2024 Home
Toggle navigation
About
News Center
Award Winners
Program
Program
Student Program
Learning Formats
Plenary Sessions
Posters
Program Committee
Digital Conference Pass
Exhibits & Sponsorship
Sponsor List
Media Partners
Exhibitor Directory
Photo Gallery
ISPOR
Europe 2024
17 - 20 November
Home
Events
Past Conferences
ISPOR Europe 2024
Program
Plenary Sessions
Session
Analysis of the Change of the Added Benefit and Respective Reasons in Renewed Regular Benefit Assessments of Orphan Drugs Due to Exceeding the Sales Threshold in Germany: Update Until Mai 2024
Nov 18, 2024, 16:00 PM
«
2531
2532
2533
2534
2535
2536
2537
2538
2539
(current)
2540
»